Cortical lesions (CLs) contribute to physical and cognitive disability in multiple sclerosis (MS). Accurate methods for visualization of CLs are necessary for future clinical studies and therapeutic trials in MS.
Daniel M. Harrison, MD, of the University of Maryland, and colleagues evaluated the clinical relevance of measures of CL burden derived from high-field magnetic resonance imaging (MRI) in MS.An observational clinical imaging study was conducted at an academic MS center. Participants included 36 individuals with MS (30 relapsing-remitting, 6 secondary or primary progressive) and 15 healthy individuals serving as controls. The study was conducted from March 10, 2010, to November 23, 2012, and analysis was performed from June 1, 2011, to September 30, 2014.
READ FULL ARTICLE From archneur.jamanetwork.com